Novartis AG (NVS) Social Stream
Novartis Ag (NVS) Price Targets From Analysts
Use the tables below to see what analysts covering Novartis Ag think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
NVS's average price target has moved down $2.07 over the prior 18 months.
Over the past 132 days, NVS's average upside potential has been 22.5%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NVS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, NVS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Novartis Ag's variance in analysts' estimates is lower than 61.32% of them.
- To contextualize these metrics, consider that out of stocks in the mega market cap category, Novartis Ag's number of analysts covering the stock is greater than 20.66% of them.
- NVS has a higher upside potential (average analyst target price relative to current price) than 42.27% of Pharmaceutical Products stocks.
- In terms of how Novartis Ag fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 430.7% of that group.
Is NVS a Buy, Hold or Sell? See the POWR Ratings now!